View the public protocol
GlaxoSmithKline, Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Humana HealthCare, Optum Epidemiology. 209452 - A targeted safety study, EPI-ZOSTER-030 VS US DB, to evaluate the safety of Shingrix in adults ≥50 years of age in the United States (EUPAS37156; Study ID 50411). Amsterdam: European Medicines Agency (EMA); 2020 Sep 11. Available from: https://catalogues.ema.europa.eu/node/3569/administrative-details
